Nanotechnology Now

Our NanoNews Digest Sponsors



Heifer International

Wikipedia Affiliate Button


android tablet pc

Home > Press > Shot in the arm for vaccine without needles and knees without pain

Justin Cooper-White and Mark Kendall
Justin Cooper-White and Mark Kendall

Abstract:
Researchers at The University of Queensland have had success in swapping their white lab coats for boardroom suits, with awards in a prestigious national business plan competition.

Shot in the arm for vaccine without needles and knees without pain

Brisbane | Posted on October 29th, 2010

Teams from the Australian Institute for Bioengineering and Nanotechnology took out the best pitch prize and audience award during the final of UQ Business School's Enterprize competition at the State Library of Queensland.

Professor Mark Kendall's team took out the Women in Technology Award on October 20, after securing 74 per cent of the audience vote while pitching their business concept to an audience, including investors.

The win recognised their work in putting together a business plan to commercialise the needle-free vaccine delivery device Nanopatch.

Nanopatch has been shown in trials to provide a protective immunisation in mice, with less than a hundredth of the dosage used compared to a needle and syringe.

Professor Justin Cooper-White's team won the i.lab award for best pitch, earning a nod from judges who are themselves investors.

The win recognised their work in putting together a business plan to commercialise Dyniform Meniscal Replacement Therapy (Dyniform-MRT).

The team is developing breakthrough technology to repair a torn or injured meniscus in the knee joint.

Dyniform-MRT is yet to undergo preclinical or human clinical trials and the earliest the product would reach the market is 2018.

The two AIBN awards follow months of work in establishing business plans, doing market analysis, preparing competitive advantage and a financial forecasts and enduring in-depth interviews with the panel of five judges.

Prof Kendall said: "Certainly this award provides a form of external validation, not only for the Nanopatch technology as a commercial prospect, but also our commercialisation strategy."

"Our ambition is for Nanopatch to be taken from the current stage of animal model success through the clinic - and on to the market as a next-generation vaccine delivery device, potentially displacing the needle and syringe.

"This progression requires commercialisation and partnership with the right players."

Prof Cooper-White said the best pitch award showed his team was on the right track with both its knee-joint technology and the way it was received in the business and investment fields.
"It gives us a better sense of how good our product is and how competitive we are. It gives us visibility and helps us build momentum with our partnering strategy to take the technology out of the lab and into the wider world."

####

For more information, please click here

Contacts:
Media: Professor Mark Kendall (07 3346 4203, 0431 162 391) or Professor Justin Cooper-White (3346 3858)

Copyright © University of Queensland

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Novel approach to magnetic measurements atom-by-atom October 1st, 2014

Nanoparticles Accumulate Quickly in Wetland Sediment: Aquatic food chains might be harmed by molecules "piggybacking" on carbon nanoparticles October 1st, 2014

'Stealth' nanoparticles could improve cancer vaccines October 1st, 2014

Stressed Out: Research Sheds New Light on Why Rechargeable Batteries Fail October 1st, 2014

Academic/Education

Yale University and Leica Microsystems Partner to Establish Microscopy Center of Excellence: Yale Welcomes Scientists to Participate in Core Facility Opening and Super- Resolution Workshops October 20 Through 31, 2014 September 30th, 2014

Rice launches Center for Quantum Materials: RCQM will immerse global visitors in cross-disciplinary research September 30th, 2014

Biosensors Get a Boost from Graphene Partnership: $5 Million Investment Supports Dozens of Jobs and Development of 300mm Fabrication Process and Wafer Transfer Facility September 18th, 2014

Malvern technology delivers Malvern reliability in multi-disciplinary lab at Queen Mary University London September 9th, 2014

Nanomedicine

'Stealth' nanoparticles could improve cancer vaccines October 1st, 2014

New Absorber Will Lead to Better Biosensor: Biosensors are more sensitive and able to detect smaller changes in the environment October 1st, 2014

Ad-REIC vaccine: A magic bullet for cancer treatment September 30th, 2014

New Topical Hemostatic Agent: Neutral Self-Assembling Peptide Hydrogel September 30th, 2014

Announcements

'Stealth' nanoparticles could improve cancer vaccines October 1st, 2014

Stressed Out: Research Sheds New Light on Why Rechargeable Batteries Fail October 1st, 2014

New Absorber Will Lead to Better Biosensor: Biosensors are more sensitive and able to detect smaller changes in the environment October 1st, 2014

Graphene chips are close to significant commercialization October 1st, 2014

Grants/Awards/Scholarships/Gifts/Contests/Honors/Records

A Heartbeat Away? Hybrid "Patch" Could Replace Transplants: TAU researcher harnesses gold nanoparticles to engineer novel biocompatible cardiac patch September 30th, 2014

Teijin Aramidís carbon nanotube fibers awarded with Paul Schlack prize: New generation super fibers bring wave of innovations to fiber market September 25th, 2014

New chip promising for tumor-targeting research September 22nd, 2014

SouthWest NanoTechnologies (SWeNT) Receives NIST Small Business Innovation Research (SBIR) Phase 1 Award to Produce Greater than 99% Semiconducting Single-Wall Carbon Nanotubes September 19th, 2014

Nanobiotechnology

Ad-REIC vaccine: A magic bullet for cancer treatment September 30th, 2014

How things coil: Researchers discover that simulation technology designed for Hollywood can be used as a predictive tool for understanding fundamental engineering problems September 29th, 2014

Penn Team Studies Nanocrystals by Passing Them Through Tiny Pores September 26th, 2014

New NIH/DOE Grant for Life Science Studies at NSLS-II: Funding will support operation of three powerful experimental stations designed to reveal detailed structures of proteins, viruses, and more September 23rd, 2014

NanoNews-Digest
The latest news from around the world, FREE



  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More














ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project







© Copyright 1999-2014 7th Wave, Inc. All Rights Reserved PRIVACY POLICY :: CONTACT US :: STATS :: SITE MAP :: ADVERTISE